Why One Analyst Thinks Johnson & Johnson Reaches $280
unknown📝 Article Content
Johnson & Johnson (NYSE:JNJ) has been one of healthcare’s standout performers over the past year, with shares up 48% over the past 12 months and 16% year-to-date. The stock currently trades around $241, well above its 52-week low of $137.67. While most analysts carry more moderate forecasts, with the Street consensus sitting at $238.29, HSBC ... Why One Analyst Thinks Johnson & Johnson Reaches $280
📄 Summary
Johnson & Johnson (NYSE:JNJ) has been one of healthcare’s standout performers over the past year, with shares up 48% over the past 12 months and 16% year-to-date. The stock currently trades around $241, well above its 52-week low of $137.67. While most analysts carry more moderate forecasts, with the Street consensus sitting at $238.29, HSBC ... Why One Analyst Thinks Johnson & Johnson Reaches $280